AbstractMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system which responds to anti-inflammatory treatments in the early disease phase. However, the pathogenesis of the progressive disease phase is less well understood, and inflammatory as well as neurodegenerative mechanisms of tissue damage are currently being discussed. This review summarizes current knowledge on the interrelation between inflammation, demyelination, and neurodegeneration derived from the study of human autopsy and biopsy brain tissue and experimental models of MS
In its classical meaning multiple sclerosis (MS) denotes a demyelinating disease of the central nerv...
: Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ...
The histopathology of multiple sclerosis (MS), the most common demyelinating disorder, is the main f...
AbstractMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system whic...
The autoimmune model of multiple sclerosis (MS) pathogenesis provided for many years a useful but in...
Progressive forms of multiple sclerosis (MS) are associated with chronic demyelination, axonal loss,...
Progressive multiple sclerosis (MS) is characterized clinically by the accumulation of neurological ...
In the majority of patients multiple sclerosis starts with a relapsing remitting course (RRMS), whic...
In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodege...
To identify pathogenetic markers and potential drivers of different lesion types in the white matter...
Neurodegeneration causes inexorable loss of neurons and function in both diseases and aging. Neurode...
Objective Cortical gray matter (GM) pathology, involving demyelination and neurodegeneration, associ...
Oligodendrocyte damage is a central event in the pathogenesis of the common neuro-inflammatory condi...
Multiple sclerosis (MS) is by far the most common central nervous system inflammatory demyelinating ...
AbstractStudies aimed to elucidate the pathogenesis of the disease and to find new therapeutic optio...
In its classical meaning multiple sclerosis (MS) denotes a demyelinating disease of the central nerv...
: Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ...
The histopathology of multiple sclerosis (MS), the most common demyelinating disorder, is the main f...
AbstractMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system whic...
The autoimmune model of multiple sclerosis (MS) pathogenesis provided for many years a useful but in...
Progressive forms of multiple sclerosis (MS) are associated with chronic demyelination, axonal loss,...
Progressive multiple sclerosis (MS) is characterized clinically by the accumulation of neurological ...
In the majority of patients multiple sclerosis starts with a relapsing remitting course (RRMS), whic...
In multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system, neurodege...
To identify pathogenetic markers and potential drivers of different lesion types in the white matter...
Neurodegeneration causes inexorable loss of neurons and function in both diseases and aging. Neurode...
Objective Cortical gray matter (GM) pathology, involving demyelination and neurodegeneration, associ...
Oligodendrocyte damage is a central event in the pathogenesis of the common neuro-inflammatory condi...
Multiple sclerosis (MS) is by far the most common central nervous system inflammatory demyelinating ...
AbstractStudies aimed to elucidate the pathogenesis of the disease and to find new therapeutic optio...
In its classical meaning multiple sclerosis (MS) denotes a demyelinating disease of the central nerv...
: Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ...
The histopathology of multiple sclerosis (MS), the most common demyelinating disorder, is the main f...